# When and where you hurt can help explain the soreness *Biologic Therapy Scottsdale: blood-based shots and what soreness may mean* > Learn what the sore spot and timing may tell you, what can make soreness worse, and which changes call for medical care. Write down when the soreness starts. Also note the exact spot and the task you were doing. Those facts help because wear and strain don't feel the same. The exam still decides what needs attention. ## The sore spot helps narrow the cause Knee soreness may sit near the kneecap or deep inside. The knee may also feel stiff when you stand. Hip trouble can feel like groin soreness or an outside ache. Shoulder strain often appears when you reach or lift. Point to the exact spot during your exam. Don't settle for saying the whole joint hurts. ## Less strain can settle a short flare Long walks, stairs, yard work, and lifting can stir soreness. Cut that work back for a few days. You don't have to stop moving. Use shorter sessions and quit before the soreness turns sharp. Make one change at a time. You'll know which change actually helped. ## QC Kinetix checks the joint before offering care At QC Kinetix, regenerative treatments are blood-based shots prepared in the clinic. A medical provider is the licensed clinic worker who checks whether one may fit. PRP is a shot made with platelets, tiny blood pieces used in clotting and healing. Concentrated PRP has a larger amount of those pieces. The provider can also explain other non-surgical choices. Your exam and X-ray can't be skipped. ## Heat, swelling, or weakness can need quick care Get prompt care when the joint feels hot and looks swollen. Fever or feeling ill makes it more urgent. If an injury means you can't stand, get help. A locked joint or one that looks out of place also needs care. Call promptly for fast worsening, new weakness, or numbness. Those signs can't wait for a talk about joint shots. ## Sources 1. FDA's July 2020 final guidance 'Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use' is the document that decides whether a given orthobiologic can be used without a licence: an HCT/P may be regulated solely under section 361 only if it is minimally manipulated AND intended for homologous use, among other criteria; otherwise it is a drug or biological product requiring an approved licence or an active investigational new drug application. U.S. Food and Drug Administration — [Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and Food and Drug Administration Staff](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal). *FDA Guidance Document*, 2020. 2. FDA states verbatim of stem cell products, stromal vascular fraction (adipose-derived cells), umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products: 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2020. 3. A multicenter single-blind RCT randomised 200 patients 1:1:1 to a single injection of saline, hyaluronic acid or amniotic suspension allograft. ASA produced significant KOOS and VAS improvements maintained through 12 months with a 63.2% OMERACT-OARSI responder rate, no radiographic differences, and no concerning immunoglobulin or anti-HLA responses. Adverse events with ASA were comparable to HA, while NO treatment-emergent adverse events were reported in the saline group. Gomoll AH, et al. — [Safety and Efficacy of an Amniotic Suspension Allograft Injection Over 12 Months in a Single-Blinded, Randomized Controlled Trial for Symptomatic Osteoarthritis of the Knee.](https://pubmed.ncbi.nlm.nih.gov/33716121/). *Arthroscopy*, 2021. DOI: 10.1016/j.arthro.2021.02.044. 4. A JBJS systematic review screened 420 papers on intra-articular cellular therapy for knee OA and focal cartilage defects and found only SIX studies at Level III evidence or higher, covering 300 knees, with wide variation in cell source, cell characterisation, adjuvant therapy and outcome assessment. All six reported improvement and no major adverse events, but the authors concluded the improvement was modest, a placebo effect could not be disregarded, and no consensus exists on indications, cell sources, preparation or delivery. Chahla J, Piuzzi NS, et al. — [Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee: A Systematic Review of the Literature and Study Quality Analysis.](https://pubmed.ncbi.nlm.nih.gov/27655978/). *Journal of Bone and Joint Surgery (American)*, 2016. DOI: 10.2106/JBJS.15.01495. 5. FDA's patient and consumer notice on regenerative medicine states that it has received reports of BLINDNESS, TUMOUR FORMATION, neurological events, bacterial infections including life-threatening blood infections, unwanted immune reactions, and cells migrating and forming unintended tissue, following the use of unapproved regenerative medicine products - a list that explicitly includes stromal vascular fraction, amniotic fluid, Wharton's jelly, ortho-biologics and exosomes. It also warns that a product's presence on clinicaltrials.gov, or a firm's registration with FDA, does NOT mean the product is legally marketed. U.S. Food and Drug Administration — [Important Patient and Consumer Information About Regenerative Medicine Therapies](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies). *FDA (Center for Biologics Evaluation and Research)*, 2021. ## An exam can give you a clear next step Home care has limits. A medical provider checks your joint and explains the likely cause. After that exam, QC Kinetix may offer non-surgical care. You'll hear the cost, time, and effort before deciding. You can ask questions and leave without booking treatment. That's still a useful visit. Book a free consultation: --- Plain help for soreness and your next step. Biologic therapy Scottsdale means blood-based shots for joint soreness. See what you can try now and when an exam makes sense. Plain advice for an aching joint and local care choices. This site is written, funded and operated by the owners of the QC Kinetix clinics in the Phoenix area, including the Scottsdale location on East Mountain View Road. It is a commercial publication and it says so on every page. Copyright 2026 Scottsdale Biologics Register. Educational content only; nothing here is medical advice or a diagnosis, and no page on this site can assess your joint.